Hormonal Management of Heavy Menstrual Bleeding in Adolescents
NCT06740929 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 163
Last updated 2026-05-12
Summary
The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.
Conditions
- Heavy Menstrual Bleeding
- Bleeding Disorder
Sponsors & Collaborators
-
University Hospital, Geneva
lead OTHER
Eligibility
- Max Age
- 25 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-17
- Primary Completion
- 2027-07-31
- Completion
- 2027-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Stopping Heavy Periods Project
NCT02002260 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial
NCT00474851 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
NCT00253019 ·Status: COMPLETED
-
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 ·Status: COMPLETED
-
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
NCT06394999 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
NCT00318799 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study
NCT01428713 ·Status: COMPLETED ·Phase: NA
-
Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
NCT00350480 ·Status: COMPLETED ·Phase: NA
-
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
NCT07229209 ·Status: COMPLETED ·Phase: NA
-
Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding
NCT03368898 ·Status: COMPLETED
-
Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes
NCT00946192 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
NCT01461824 ·Status: COMPLETED ·Phase: PHASE3
-
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
NCT06634719 ·Status: RECRUITING ·Phase: NA
-
Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
NCT01776203 ·Status: TERMINATED ·Phase: PHASE4
-
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
NCT01638923 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Leptin for the Treatment of Hypothalamic Amenorrhea
NCT00130117 ·Status: COMPLETED ·Phase: PHASE2
-
Birth Control Patch Study
NCT00984789 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
NCT00128726 ·Status: COMPLETED
-
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
NCT00195559 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
NCT00746096 ·Status: COMPLETED ·Phase: PHASE3
-
Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene
NCT00729404 ·Status: TERMINATED ·Phase: PHASE2
-
US Cycle Control and Blood Pressure Study
NCT00920985 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
NCT00360490 ·Status: COMPLETED ·Phase: PHASE3
-
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
NCT01148420 ·Status: COMPLETED ·Phase: PHASE4